SK35199A3 - Use of benzopyranols to treat neurological disorders - Google Patents
Use of benzopyranols to treat neurological disorders Download PDFInfo
- Publication number
- SK35199A3 SK35199A3 SK351-99A SK35199A SK35199A3 SK 35199 A3 SK35199 A3 SK 35199A3 SK 35199 A SK35199 A SK 35199A SK 35199 A3 SK35199 A3 SK 35199A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- hydrogen
- amino
- nitro
- alkoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9619492.3A GB9619492D0 (en) | 1996-09-18 | 1996-09-18 | Novel treatment |
| PCT/EP1997/005168 WO1998011890A1 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK35199A3 true SK35199A3 (en) | 2000-07-11 |
Family
ID=10800127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK351-99A SK35199A3 (en) | 1996-09-18 | 1997-09-15 | Use of benzopyranols to treat neurological disorders |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0939630B1 (bg) |
| JP (1) | JP2001500520A (bg) |
| KR (1) | KR20000036184A (bg) |
| CN (1) | CN1230885A (bg) |
| AP (1) | AP9901473A0 (bg) |
| AR (1) | AR008838A1 (bg) |
| AT (1) | ATE270102T1 (bg) |
| AU (1) | AU730465B2 (bg) |
| BG (1) | BG103252A (bg) |
| BR (1) | BR9712030A (bg) |
| CA (1) | CA2266681A1 (bg) |
| DE (1) | DE69729735T2 (bg) |
| DZ (1) | DZ2311A1 (bg) |
| EA (1) | EA199900306A1 (bg) |
| ES (1) | ES2223075T3 (bg) |
| GB (1) | GB9619492D0 (bg) |
| HU (1) | HUP9904638A3 (bg) |
| ID (2) | ID23175A (bg) |
| IL (1) | IL128786A0 (bg) |
| MA (1) | MA24321A1 (bg) |
| NO (1) | NO991292D0 (bg) |
| NZ (1) | NZ334271A (bg) |
| OA (1) | OA10998A (bg) |
| PE (1) | PE109898A1 (bg) |
| PL (1) | PL332313A1 (bg) |
| SK (1) | SK35199A3 (bg) |
| TR (1) | TR199900527T2 (bg) |
| UY (1) | UY24717A1 (bg) |
| WO (1) | WO1998011890A1 (bg) |
| ZA (1) | ZA978359B (bg) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7119214B2 (en) * | 2004-04-13 | 2006-10-10 | Cephalon France | Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| MX2010013313A (es) * | 2008-06-05 | 2011-05-30 | Minster Res Ltd | Tratamientos novedosos. |
| WO2009147441A2 (en) * | 2008-06-05 | 2009-12-10 | Minster Research Limited | Novel treatments |
| WO2011067607A1 (en) * | 2009-12-03 | 2011-06-09 | Minster Research Ltd | Treatment of infectious diseases |
| CA2774715C (en) | 2009-07-27 | 2018-04-03 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| US20130018091A1 (en) * | 2009-12-03 | 2013-01-17 | Peter Blower | Treatment of allodynia and hyperalgesia |
| CN103096977B (zh) | 2010-07-02 | 2017-02-15 | 吉利德科学公司 | 作为离子通道调节剂的稠杂环化合物 |
| CA2834164A1 (en) | 2011-05-10 | 2012-11-15 | Gilead Sciences, Inc. | Fused benzoxazinones as ion channel modulators |
| NO3175985T3 (bg) | 2011-07-01 | 2018-04-28 | ||
| TWI478908B (zh) | 2011-07-01 | 2015-04-01 | Gilead Sciences Inc | 作為離子通道調節劑之稠合雜環化合物 |
| CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) * | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| US5510375A (en) * | 1993-11-19 | 1996-04-23 | Warner-Lambert Company | Coumarin derivatives as protease inhibitors and antiviral agents |
| DE69524871T2 (de) * | 1994-06-10 | 2002-08-22 | Smithkline Beecham Plc | Benzopyrans und deren verwendung als therapeutische mittel |
| GB9411635D0 (en) * | 1994-06-10 | 1994-08-03 | Smithkline Beecham Plc | Novel treatment |
-
1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
-
1997
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Application Discontinuation
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Application Discontinuation
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 EP EP97909300A patent/EP0939630B1/en not_active Expired - Lifetime
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
-
1999
- 1999-03-15 BG BG103252A patent/BG103252A/bg unknown
- 1999-03-17 NO NO991292A patent/NO991292D0/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001500520A (ja) | 2001-01-16 |
| ID23175A (id) | 2000-03-23 |
| EA199900306A1 (ru) | 1999-08-26 |
| GB9619492D0 (en) | 1996-10-30 |
| BG103252A (bg) | 1999-09-30 |
| DZ2311A1 (fr) | 2002-12-28 |
| PL332313A1 (en) | 1999-08-30 |
| OA10998A (en) | 2003-03-04 |
| HUP9904638A2 (hu) | 2001-05-28 |
| BR9712030A (pt) | 1999-08-24 |
| AR008838A1 (es) | 2000-02-23 |
| EP0939630B1 (en) | 2004-06-30 |
| AU730465B2 (en) | 2001-03-08 |
| NZ334271A (en) | 2001-03-30 |
| DE69729735D1 (de) | 2004-08-05 |
| CN1230885A (zh) | 1999-10-06 |
| UY24717A1 (es) | 2001-08-27 |
| MA24321A1 (fr) | 1998-04-01 |
| IL128786A0 (en) | 2000-01-31 |
| AU4704797A (en) | 1998-04-14 |
| CA2266681A1 (en) | 1998-03-26 |
| HUP9904638A3 (en) | 2001-08-28 |
| TR199900527T2 (xx) | 1999-06-21 |
| NO991292L (no) | 1999-03-17 |
| KR20000036184A (ko) | 2000-06-26 |
| DE69729735T2 (de) | 2005-07-14 |
| ZA978359B (en) | 1999-03-17 |
| ID19542A (id) | 1998-07-23 |
| AP9901473A0 (en) | 1999-03-31 |
| EP0939630A1 (en) | 1999-09-08 |
| ES2223075T3 (es) | 2005-02-16 |
| ATE270102T1 (de) | 2004-07-15 |
| WO1998011890A1 (en) | 1998-03-26 |
| NO991292D0 (no) | 1999-03-17 |
| PE109898A1 (es) | 1999-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU743915B2 (en) | Use of sulphinyl benzhydryl derivatives for treating drug-induced sleepiness | |
| US6589986B2 (en) | Methods of treating anxiety disorders | |
| SK35199A3 (en) | Use of benzopyranols to treat neurological disorders | |
| US5466700A (en) | Anesthetic use of N-phenyl-N-(4-piperidinyl)amides | |
| JPH01224316A (ja) | 医薬製剤 | |
| TWI304735B (en) | Carbamate compounds for use in the treatment of pain | |
| MX2010013312A (es) | Tratamientos novedoos. | |
| RU2292881C2 (ru) | Соединения карбамата для применения при профилактике или лечении тревожных расстройств | |
| KR20010032009A (ko) | 수면성 무호흡의 치료에 미타자핀을 사용하는 방법 | |
| FI120403B (fi) | 4-(2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena | |
| KR20000075896A (ko) | 안면 수술에서의 레보부피바카인의 용도 | |
| US6492415B2 (en) | Use of benzopyranols to treat neurological disorders | |
| EP0271271A2 (en) | Pharmaceutical preparations | |
| JP7247894B2 (ja) | ＦＰ作動薬とβ遮断薬を含有する緑内障治療剤 | |
| CZ92999A3 (cs) | Farmaceutický prostředek pro léčbu a/nebo profylaxi neurologických poruch a použití sloučenin obsahujících fosfor k výrobě léčiva | |
| JP4362368B2 (ja) | 神経因性疼痛および群発および偏頭痛に伴う疼痛の防止または処置に使用するためのカルバメート化合物 | |
| JP2008184396A (ja) | 神経損傷に起因する身体機能障害の予防及び治療のための医薬 | |
| SE9401965D0 (sv) | New compounds | |
| JP2003504396A (ja) | マクロライド化合物の新規用途 | |
| JP2002512189A (ja) | パロキセチンを用いる全般不安症の治療 | |
| JP2003267871A (ja) | 放射線障害予防剤 | |
| KR20040075871A (ko) | 알파-글루코시다제 저해제 및 ４-옥소부탄산을 포함하여이루어지는 약제학적 조성물 및 당뇨병을 치료하기 위한이의 용도 | |
| JPS63165317A (ja) | 製薬生成物 | |
| JPWO2004013107A1 (ja) | 脊髄損傷による障害の予防及び／又は治療のための医薬 | |
| HUT72589A (en) | Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms |